Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies
Clinical trial NCT04277637 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04277637
- Sponsor
- BeOne Medicines
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-24
- Primary completion
- 2027-05-31
- Enrollment
- 437
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.